Know What's Happening in Technology

AI‑Enhanced Depression Screening Merges LLMs with Psychometric Tools for Faster, Nuanced Diagnosis
NewsApr 16, 2026

AI‑Enhanced Depression Screening Merges LLMs with Psychometric Tools for Faster, Nuanced Diagnosis

Researchers publishing in JMIR Formative Research unveiled an AI‑driven depression screening method that pairs large language models with standard psychometric scales, delivering real‑time, nuanced assessments. The hybrid approach promises higher detection accuracy while preserving the speed of traditional tools.

By Pulse
UT Southwestern Study Finds Brain Cells Crucial to Endurance Performance
NewsApr 16, 2026

UT Southwestern Study Finds Brain Cells Crucial to Endurance Performance

UT Southwestern Medical Center announced that new research identifies distinct brain cells that regulate endurance, showing stamina is not solely muscle‑based. The finding could pave the way for therapies that mimic exercise benefits for people unable to work out.

By Pulse
Ketone Ester Cut Alcohol Cravings in Small Study, Offering New Biohack
NewsApr 16, 2026

Ketone Ester Cut Alcohol Cravings in Small Study, Offering New Biohack

Researchers led by Xinyi Li reported that a single 395 mg/kg dose of a ketone ester supplement sharply reduced alcohol cravings in participants with alcohol use disorder and redirected brain metabolism from glucose to ketones. The pilot study, published in Psychiatry...

By Pulse
All‑Bands‑5G‑A Standard Gains Momentum as AI Traffic Set to Triple by 2030
NewsApr 16, 2026

All‑Bands‑5G‑A Standard Gains Momentum as AI Traffic Set to Triple by 2030

Telecom operators worldwide are moving to Huawei's All‑Bands‑5G‑A architecture to cope with AI‑driven traffic that could triple by 2030. The shift expands low, mid and high‑frequency spectrum use, promises energy‑efficient performance and opens fresh monetisation paths beyond basic connectivity.

By Pulse
J&J Lifts 2026 Sales Outlook to $100 B, Defying Pricing Headwinds
NewsApr 16, 2026

J&J Lifts 2026 Sales Outlook to $100 B, Defying Pricing Headwinds

Johnson & Johnson announced a 2026 sales guidance of $99.5‑$100.5 billion, topping the Street’s $98.9 billion consensus. The raise comes after a $3.05 billion acquisition and a pricing‑cost deal, underscoring strong oncology momentum and operational resilience.

By Pulse
GrowthLoop Unveils Composable AI Platform for Real‑Time Causal Marketing
NewsApr 16, 2026

GrowthLoop Unveils Composable AI Platform for Real‑Time Causal Marketing

GrowthLoop announced the launch of its Composable AI Decisioning platform, a data‑cloud native system that gives marketers causal insight and real‑time optimization. The New York‑based firm says the tool replaces correlation‑based AI with outcome‑driven decisioning, promising higher revenue and lifetime‑value...

By Pulse
Will Apple Finally Deliver the Long‑Desired Second Screen?
SocialApr 16, 2026

Will Apple Finally Deliver the Long‑Desired Second Screen?

I wonder if Apple will ever acknowledge this and give us the second screen we all crave

By Taylor Lorenz
Ahold Delhaize Launches Product Carbon Footprinting to Boost Supply‑Chain Transparency
NewsApr 16, 2026

Ahold Delhaize Launches Product Carbon Footprinting to Boost Supply‑Chain Transparency

Ahold Delhaize announced the rollout of product carbon‑footprinting (PCF) tools, partnering with sustainability data firm HowGood to capture emissions for hundreds of thousands of items. The move supports its pledge to slash Scope 3 greenhouse‑gas emissions 30.3% by 2030 and underpins...

By Pulse
Albertsons Uses AI Personalization and Dynamic Pricing to Keep Sales Growing Amid Consumer Pullback
NewsApr 16, 2026

Albertsons Uses AI Personalization and Dynamic Pricing to Keep Sales Growing Amid Consumer Pullback

Albertsons said AI‑powered personalization, loyalty growth and dynamic pricing helped it post a 0.7% rise in identical‑store sales in Q4 and a 2% gain for the full year, despite lower‑income shoppers cutting back amid higher fuel costs and tariffs. The...

By Pulse
FDA Issues Draft Guidance to Standardize Safety Assessment of Genome‑Editing Gene Therapies
NewsApr 16, 2026

FDA Issues Draft Guidance to Standardize Safety Assessment of Genome‑Editing Gene Therapies

The U.S. Food and Drug Administration today released a draft guidance titled “Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next‑Generation Sequencing.” The document sets uniform pre‑clinical and IND requirements for ex vivo and in vivo CRISPR‑based...

By Pulse
Spingence and Digital Base Unveil Secure Internal Data-Connected AI Platform at AI EXPO Tokyo 2026
NewsApr 16, 2026

Spingence and Digital Base Unveil Secure Internal Data-Connected AI Platform at AI EXPO Tokyo 2026

Spingence Technology and Japan’s Digital Base unveiled an "Internal Data-Connected AI Platform" at the AI Expo in Tokyo, targeting enterprises that need to keep sensitive data on‑premises. The solution combines Spingence’s AI infrastructure with Digital Base’s integration tools to enable...

By The Manila Times – Business
TGT Technology Group Shines at Japan IT Week Spring 2026, Empowering Japanese Enterprises with Global Smart Connectivity Through vSIM and...
NewsApr 16, 2026

TGT Technology Group Shines at Japan IT Week Spring 2026, Empowering Japanese Enterprises with Global Smart Connectivity Through vSIM and...

TGT Technology Group used Japan IT Week Spring 2026 to launch its AI‑powered vSIM/eSIM portfolio for Japanese enterprises, highlighting card‑less global connectivity across devices such as MiFi, CPE, and in‑vehicle units. The suite, built on the company’s proprietary cloud communications...

By The Manila Times – Business
Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)
NewsApr 16, 2026

Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)

Chinese biopharma Mabwell announced that the National Medical Products Administration has accepted a supplemental biologics license application for MAIWEIJIAN, its denosumab biosimilar. The 120 mg injection, already approved in China for giant cell tumor of bone and in Pakistan, is now...

By The Manila Times – Business
Axtria Acquires Conexus Solutions to Fuse AI and CRM in Life Sciences
NewsApr 16, 2026

Axtria Acquires Conexus Solutions to Fuse AI and CRM in Life Sciences

Axtria announced the acquisition of Conexus Solutions, a leading CRM transformation partner, to combine its agentic AI platform with Conexus' Veeva and Salesforce capabilities. The deal, disclosed on April 15, 2026, positions Axtria to deliver an integrated intelligence layer for...

By Pulse